British American Tobacco PLC (BTI) Stock Price Today
Aura AI Summary
Key Stats
- $120.19BMarket Cap
- 3,726,915Volume
- Consumer StaplesSector
- $66.7052W High
- $50.3952W Low
- 86 DaysTypical Hold Time
- $163.22BEnterprise Value
- 5.96%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track British American Tobacco PLC (BTI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, British American Tobacco PLC has traded between a low of $50.39 and a high of $66.7, highlighting its annual price range. Buy and sell British American Tobacco PLC shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About British American Tobacco PLC
Following the acquisition of Reynolds American, British American Tobacco is neck-and-neck with Philip Morris International to be the largest listed global tobacco company--slightly larger than PMI on net revenue, but slightly smaller on total tobacco volume. British American's Global Drive Brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans, and it also owns Newport and Camel in the U.S. The firm also sells vapor e-cigarettes, including its Vype brand, heated tobacco, with Glo, as well as roll- your-own and smokeless tobacco products. The company holds 31% of ITC Limited, the leading Indian cigarette-maker.
Most Recent News
GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...

Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...

Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.